Wellness Engagement Intervention for Obesity

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Virginia Commonwealth University, Richmond, VA
Obesity
Wellness Engagement Intervention - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

African American adults that live in economically disadvantaged areas are at an increased risk for obesity and cardiometabolic disease. The treatment program being tested in this research study aims to address these factors and increase outcomes for the study population. The purpose of this research study is to find out about the feasibility and acceptability of using house chats (HC) as a model for a weight loss program in a real-world, community-based setting.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Obesity

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: 18 months

12 weeks
Acceptability: Attendance
Acceptability: Retention
Feasibility: Delivery Model
18 months
Feasibility: House Chat Leaders (HCL)
Feasibility: Participants

Trial Safety

Safety Progress

1 of 3

Other trials for Obesity

Trial Design

2 Treatment Groups

Delayed Intervention
1 of 2
Intervention
1 of 2
Active Control
Experimental Treatment

10 Total Participants · 2 Treatment Groups

Primary Treatment: Wellness Engagement Intervention · No Placebo Group · N/A

Intervention
Behavioral
Experimental Group · 1 Intervention: Wellness Engagement Intervention · Intervention Types: Behavioral
Delayed InterventionNoIntervention Group · 1 Intervention: Delayed Intervention · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 18 months
Closest Location: Virginia Commonwealth University · Richmond, VA
Photo of virginia commonwealth university 1Photo of virginia commonwealth university 2Photo of virginia commonwealth university 3
2019First Recorded Clinical Trial
15 TrialsResearching Obesity
526 CompletedClinical Trials

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
609 Previous Clinical Trials
342,375 Total Patients Enrolled
26 Trials studying Obesity
5,583 Patients Enrolled for Obesity
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,094 Previous Clinical Trials
5,051,483 Total Patients Enrolled
392 Trials studying Obesity
1,479,422 Patients Enrolled for Obesity
Moghboeba Mosavel, PhDPrincipal InvestigatorVirginia Commonwealth University

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are willing to engage in healthy lifestyle changes (e.g.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.